The Midwest Athletes Against Childhood Cancer (MACC) Fund has declared that it will fund each of eight separate grant requests made by the Departments of Pediatrics and Human Oncology. The grants will fund each project for $100,000 over the next two years. Congratulations to all of the researchers involved.
- Christian Capitini, MD, “Exploitation of the STAT1-BCL2 Axis to Dissect GVL from GVHD”
- Ken DeSantes, MD, “Treatment of Relapsed or Refractory Neuroblastoma with Ex-Vivo Activated and Expanded Haploindentical NK Cells and Continuous Infusion Hu14.18-IL2ts,” and “Support for clinical research infrastructure”
- Jacquelyn Hank, PhD, “Monitoring of Immune Network Responses in Pediatric Neuroblastoma Patients Treated with ch14.18, hu14.18K322A or hu14.18-IL2 Immunocytokine (IC)”
- Mario Otto, MD, PhD, “CLR-1404: A Tumor-selective Alkyl Phospholipid Analog for the Treatment of Pediatric Solid Malignancies,” and “Effect of Zoledronate on Engraftment and T-cell Development after TCRab/CD19-depleted Hematopoietic Stem Cell Transplantation”
- Alexander Rakhmilevich, MD, PhD, “Combining ADCC, Macrophage Activation and Checkpoint Blockade for Treatment of Experimental Cancer”
- Paul Sondel, MD, PhD, “Enhancing Immunocytokine Efficacy in Neuroblastoma: Synergy with Radiation Therapy (RT) and Development of 2nd Generation Immunocytokines (IC)”